|
End-of-day quote
Shenzhen S.E.
04/09/2026
|
5-day change | 1st Jan Change | ||
| 8.470 CNY | +0.47% |
|
-6.10% | +6.68% |
| 08-26 | Beijing Beilu Pharmaceutical Co., Ltd. Proposes Interim Cash Dividend for 2026 | CI |
| 08-24 | Beijing Beilu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Company Valuation: Beijing Beilu Pharmaceutical Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,727 | 4,523 | 3,208 | 3,503 | 3,050 | 4,469 |
| Change | - | -4.32% | -29.09% | 9.2% | -12.92% | 46.53% |
| Enterprise Value (EV) 1 | 4,417 | 4,204 | 3,088 | 3,545 | 3,239 | 4,300 |
| Change | - | -4.82% | -26.55% | 14.81% | -8.63% | 32.77% |
| P/E | 26.6x | 36.7x | 326x | -47.5x | 207x | 44.1x |
| PBR | 2.71x | 2.44x | 1.81x | 2.12x | 1.83x | 1.98x |
| PEG | - | -1.2x | -3.5x | 0x | -2x | 0x |
| Capitalization / Revenue | 5.71x | 5.36x | 4.19x | 3.93x | 3.1x | 3.71x |
| EV / Revenue | 5.34x | 4.98x | 4.03x | 3.98x | 3.29x | 3.57x |
| EV / EBITDA | 24.6x | 24.2x | 44.7x | 150x | 22.6x | 23.5x |
| EV / EBIT | 32.2x | 37.7x | -603x | -62.4x | 60.8x | 48.9x |
| EV / FCF | -1,039x | -34.3x | -52.9x | -20.1x | -134x | -25.5x |
| FCF Yield | -0.1% | -2.92% | -1.89% | -4.97% | -0.75% | -3.93% |
| Dividend per Share 2 | 0.06 | 0.07 | 0.07 | - | 0.05 | - |
| Rate of return | 0.63% | 0.76% | 1.07% | - | 0.81% | - |
| EPS 2 | 0.36 | 0.25 | 0.02 | -0.15 | 0.03 | 0.18 |
| Distribution rate | 16.7% | 28% | 350% | - | 167% | - |
| Net sales 1 | 827.3 | 843.9 | 765.9 | 890.7 | 983.6 | 1,205 |
| EBITDA 1 | 179.7 | 173.6 | 69.09 | 23.6 | 143.4 | 182.7 |
| EBIT 1 | 137.3 | 111.4 | -5.124 | -56.82 | 53.24 | 87.86 |
| Net income 1 | 174.7 | 125 | 11.21 | -71.76 | 13.65 | 92.73 |
| Net Debt 1 | -310.6 | -319.3 | -120 | 42.28 | 189.1 | -168.8 |
| Reference price 2 | 9.560 | 9.180 | 6.520 | 7.120 | 6.200 | 7.940 |
| Nbr of stocks (in thousands) | 494,494 | 492,718 | 491,956 | 491,935 | 491,935 | 562,873 |
| Announcement Date | 18/03/21 | 29/03/22 | 23/04/23 | 21/04/24 | 17/04/25 | 21/04/26 |
1CNY in Million2CNY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 734M | |
| 32.72x | 11.9x | 24.26x | 0.6% | 1,024B | |
| 30.62x | - | - | 1.95% | 663B | |
| 32.73x | 7.6x | 15.8x | 2.67% | 453B | |
| 19.89x | 4.73x | 11.71x | 2.8% | 352B | |
| 22.72x | 5.84x | 14.51x | 2.7% | 304B | |
| 20.87x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.66x | 7.14x | 13.15x | 2.31% | 236B | |
| 13.33x | 4.82x | 10.06x | 3.78% | 206B | |
| -46.14x | 6.65x | 25.95x | 2.18% | 187B | |
| Average | 17.16x | 6.62x | 15.96x | 2.34% | 367.91B | |
| Weighted average by Cap. | 24.05x | 7.99x | 17.80x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 300016 Stock
- Valuation Beijing Beilu Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
